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Abstract 
Using results from two contingent valuation surveys conducted in Canada and the United 
States, we explore the effect of a latency period on willingness to pay (WTP) for reduced 
mortality risk using both structural and reduced form approaches. We find that delaying the  
time at which the risk reduction occurs by 10 to 30 years significantly reduces WTP for 
respondents aged 40 to 60 years. Additionally, we estimate implicit discount rates equal to 8% 
for Canada and 4.5% for the United States—both well within the range established previously in 
the literature.  
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Willingness to Pay for Mortality Risk Reductions: Does Latency 
Matter? 
Anna Alberini, Maureen Cropper, Alan Krupnick, and Nathalie B. Simon∗ 
1. Introduction 
For many environmental policies, such as those that seek to reduce exposure to 
carcinogens, the reduction in the risk of dying occurs many years after the initial investment in 
pollution reduction. To value the benefits of such policies, it is necessary to ask people how 
much they would be willing to pay now for a reduction in risk that takes place in the future. 
Economic theory suggests that willingness to pay (WTP) for a future risk reduction should be 
less than WTP for an immediate risk reduction of the same size. This occurs for two reasons: (1) 
the individual may not be alive to enjoy the risk reduction, and (2) if the individual is willing to 
substitute consumption for risk, the risk reduction should be discounted at the consumption rate 
of discount. A key question for policy is exactly how much WTP is reduced by a gap between 
the initiation of a program and time at which the risk reduction is delivered. 
In a recent contingent valuation survey administered in Canada (Krupnick et al., 2002) 
and the United States (Alberini et al., forthcoming), we asked individual respondents how much 
they would be willing to pay today for a reduction in their risk of dying at age 70. In this paper, 
we use the responses to such payment questions to produce estimates of mean and median 
willingness to pay for the future risk reduction. Specifically, we present three sets of results: (1) a 
reduced-form model of WTP for the future risk reduction that examines how WTP varies with 
respondent age, income, health status, expected health status in the future, and self-assessed 
probability of survival until age 70; (2) a structural model that estimates the discount rate 
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implicit in WTP responses; and (3) a comparison of WTP for the future risk reduction with WTP 
for a risk reduction of the same size that occurs today.  
In our reduced-form model, we find that WTP today for a risk reduction at age 70 is, as 
prescribed by economic theory, lower for persons who have a lower self-assessed chance of 
surviving to age 70 and lower for persons who believe their health will be worse at age 75 than it 
is today. In our structural model, which assumes (as predicted by the life-cycle model) that WTP 
today for a risk reduction at age 70 equals what the individual would pay for a current risk 
reduction at age 70 discounted to the present, we estimate the average discount rate at 8% for our 
Canada sample and 4.5% for our U.S. sample. These estimates are in line with those in Viscusi 
and Moore (1989), 1–14%; Horowitz and Carson (1990), 4.5%; and Johannesson and Johansson 
(1996), 0.3 and 1.3%. Most importantly for policy, we find that WTP today for a risk reduction 
at age 70 is, for persons aged 40–60, less than half of WTP for a current risk reduction.  
The remainder of this paper is organized as follows. Section 1 presents the life-cycle 
model with uncertain lifetime and reviews its implications for willingness to pay for a reduction 
in the conditional probability of dying at any age. It also elaborates on our plan of analysis. 
Section 2 discusses the administration and structure of our survey. Section 3 presents our 
econometric models and Section 4 our results. We summarize our findings in Section 5. 
2. Theoretical Framework and Plan of Analysis 
2.1 The Value of Mortality Risk Changes in the Life-Cycle Model 
To provide a framework for our empirical work, in this section we derive WTP for a 
change in the conditional probability of dying (at any age) in the context of the life-cycle model 
with uncertain lifetime (Cropper and Sussman, 1990; Cropper and Freeman, 1991). The model 
assumes that at age j the individual chooses a future consumption stream that maximizes 
expected lifetime utility, 
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where   is the present value of expected utility of lifetime consumption, U  is utility of 
consumption at age t, q  is the probability that the individual survives to age t, given that he or 
she is alive at age j, and δ is the subjective rate of time preference. We assume that (1) is 
maximized subject to a budget constraint that allows the individual to invest in annuities and to 
borrow via life-insured loans (Yaari, 1965). This is equivalent to assuming that the present value 
of expected consumption equals the present value of expected earnings plus initial wealth, 
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where r is the riskless rate of interest,   is income at time t, and W  is initial wealth.  t y j
Now consider a program that alters Dk, the conditional probability of dying at age k, 
given that the individual survives to that age. Since qj,t = (1-Dj)(1-Dj+1). . . (1-Dt-1), any program 
that alters Dk will necessarily alter the probability of surviving to all future ages. For small 
changes in Dk, willingness to pay may be written as the product of the rate at which the 
individual is willing to trade wealth Wj for a change in Dk, which we term VSLj,k, times the size 
of the change in Dk,  
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Applying the Envelope Theorem to the Lagrangian function formed by (1) and (2), the 
rate at which the individual substitutes current wealth for Dk may be written (Cropper and 
Sussman, 1990) as: 
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Equation (4) says that the value of a change in the probability of dying at age k equals the loss in 
expected utility from age k+1 onward, converted to dollars by dividing by the marginal utility of 
income (λj). Added to this is the effect of a change in Dk on the budget constraint. Cropper and 
Sussman (1990) show that, by substituting first-order conditions for utility maximization into (4) 
and rearranging terms, WTP at age j for a risk reduction at age k equals WTP for a current risk 
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reduction at age k multiplied by the probability of surviving to age k and discounted to the 
present at the monetary rate of discount, 
 WTP .1              (5)  k k
k j
k j k j WTP r q , , , ) 1 (
− + =
2.2 Plan of the Analysis 
Our empirical work focuses on equation (5), and its goal is three-fold. First, as a test of 
internal validity of responses, we estimate a reduced-form version of (5) for persons for whom 
40  ≤  j  ≤ 60 and k = 70. Equation (5) suggests that WTPj,70 should be lower the lower the 
probability of surviving to age 70 (qj,70) and should increase with current age (j), holding qj,70 
constant.  WTP70,70 should be higher for wealthier respondents and may depend on the 
respondents’ estimate of their health after age 70. The impact of other variables (such as, 
education) on WTPj,70 is, however, ambiguous.  
Second, we then use equation (5) to estimate respondent discount rates (r). Because our 
survey elicits WTP for a current risk reduction (for persons of different ages) we can use models 
described elsewhere (Alberini et al., forthcoming) to estimate WTP70,70 for each respondent. 
Given the respondent’s estimate of qj,70, we estimate a log-linear version of (5), where (  




)] 70 ( exp[ − j r  to obtain an estimate of the interest rate facing 
respondents: 
) 70 ( ln ln ln 70 , 70 , 70 70 , − ⋅ + + = j r q WTP WTP j j .           (6) 
On appending an error term, equation (6) becomes a regression model where the discount 
rate can be estimated as the coefficient on (j – 70), the time until the risk reduction takes place, 
as long as the latter varies across respondents.  
                                                 
1 Equation (5) of course holds for VSLj,k and VSLk,k as well. 
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Finally, we use the responses to WTP questions for current and future risk reductions to 
estimate WTPj,k/WTPj,j—that is, to see by how much WTP is reduced when the risk valued 
occurs in the future. Equation (5) does not necessarily imply that WTPj,j > WTPj,k; however, if 
WTPj,j ≥ WTPk,k—if WTP for a given risk reduction is no larger at age 70 than between ages 40 
and 60—equation (5) indeed implies that WTPj,j > WTPj,k. The question of interest for policy is 
exactly what the ratio of WTPj,k/WTPj,j is. 
3. Survey Administration and Structure 
Our survey instrument was administered in Canada in 1999 and in the United States in 
2000.2 In the Canada study, the questionnaire was self-administered by respondents using   
a computer at a centralized facility in Hamilton, Ontario. Study participants were recruited 
through random digit dialing. In the United States, we drew a national sample from the panel of 
consumers maintained by Knowledge Networks. The sample received and filled out the 
questionnaire via Web-TV.  
The questionnaire began by asking respondents to provide information about themselves, 
including age, gender, health status. It also queried respondents about the health status of family 
members (parents and siblings), and about the age of their parents. This was followed by a 
simple tutorial on probability, at the end of which respondents were introduced to the concept of 
risk of dying. To show risk and risk changes, we used a grid of 1,000 squares. White squares 
represent survival, while red squares represent death.  
Respondents were subsequently told about their own risk of dying over the next 10 years 
(and shown this risk on the grid of squares), along with the most common causes of death for a 
person of their age and gender. When eliciting WTP for a risk reduction, it is important that 
                                                 
2 The survey instruments we used in our Canada and U.S. studies were almost identical, except for currency and 
baseline risk adjustments, and the fact that U.S. respondents were asked more detailed questions about their own 
health status and the health status and ages of family members. For more information, see Alberini et al. 
(forthcoming). 
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respondents understand that it is possible to reduce risk through a number of actions (both 
medical and nonmedical), but that doing so costs money. We described to the respondents 
common risk-reducing actions (such as exercise and medical screening or diagnostic tests), but, 
to avoid anchoring respondents to specific dollar figures, we simply told them whether these 
actions were “expensive,” “inexpensive,” or “moderately priced.” 
Respondents were asked to report information about their WTP for each of three risk 
reductions: (1) 5 in 1,000 over the next 10 years, (2) 1 in 1,000 over the next 10 years, and  
(3) 5 in 1,000, but beginning at age 70 and taking place over the subsequent 10 years.3 The  
last question was asked only of respondents aged 60 and younger. We used the dichotomous 
choice approach (“Would you purchase a product that would deliver the risk reduction in 
question at a stated price?) with a follow-up question. (See Table A.1 in the Appendix for the bid 
values used.) 
Respondents were also asked to report their subjectively assessed life expectancy and 
probability of surviving until age 70. The survey ended with sociodemographic questions, 
debriefing questions, and questions from Short Form 36 (SF-36), a questionnaire widely used to 
assess health status and functionality in the medical literature.4  
A total of 930 and 1,135 respondents completed the survey in Canada and in the United 
States, respectively. The WTP questions about the future risk reductions were answered by 650 
persons in Canada and 699 in the United States.5 We exclude from the usable samples 
                                                 
3 People were randomly assigned to one of two subsamples, “wave 1” and “wave 2.” The two subsamples received 
identical questionnaires, except for the order in which the risk reductions to be valued were presented to the 
respondents. In wave 2, the order of (i) and (ii) was reversed, but the future risk reduction was the third commodity 
to be valued in both subsamples. 
 
4 The SF-36 questions were given to respondents in a pencil-and-paper questionnaire in the Canada study, but were 
included in the web-TV questionnaire in the U.S. study. The SF-36 questions were asked at the end of both surveys. 
 
5 We remind the reader that the questions about WTP for the future risk reduction were asked of individuals up to 
60 years of age.  
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respondents who failed simple probability questions, which results in 638 respondents for the 
Canada study, and all 699 for the U.S. study.6 
4. Econometric Model 
As indicated in Section 1, we use two approaches to estimate WTP . The first is a 




) exp( β σ i i x =  and shape parameter θ (that is, an accelerated life model). This is 
equivalent to the regression equation: 
i i
i
j WTP ε β + = x
70 , log ,                (7) 
where i denotes the respondent, the error term follows the type I extreme value distribution with 
scale  θ, and the vector of regressors x includes variables thought to influence WTP. Since 
information about WTP was elicited using dichotomous choice questions with a follow-up, we 
form intervals around the respondent’s (unobserved) WTP amount, specify a double-bounded 
interval-data likelihood function, and estimate the parameters of equation (7) using the method of 
maximum likelihood.  
To test internal validity in a reduced-form context, xi includes age, gender, current and 
future health status of the respondent, education and income, and the respondent’s estimate of 
qj,70. From equation (5) we expect the coefficients on qj,70 and on age to be positive. To the extent 
that current income is correlated with wealth, it should increase WTPj,70 and so, presumably, 
                                                 
6 Following the probability tutorial, respondents were asked to identify which of two grids represented the 
individual with the higher risk and which of the two they personally would rather be. Individuals who answered 
these questions incorrectly were deleted from the sample used in this paper. 
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should a more optimistic estimate of the respondent’s health state at age 75—midway between 
the beginning (70) and ending age (80) of the risk change being valued.7 
Our second estimation approach is a structural-form approach. To implement it, we begin 
with an interval-data maximum likelihood regression for WTP for the immediate 5 in 1,000 risk 
reduction on income, gender, age group dummies, and so forth, based on the underlying 
equation:  
                  (8)  i i
i
j j WTP η γ + = x , log
where η is a Type I Extreme value error term with scale τ. We use the maximum likelihood 
estimates γˆ and τˆ  to predict what each respondent’s median WTP would be if his or her age 
were 70. We denote this prediction as  , and its logarithmic transformation as 
. 
70 , 70 PWTP
70 logPWTP , 70
In the next step, we regress   on (j–70) (j being current age),   and 
, where   is the respondent-reported probability of surviving until age 70. 
Following equation (6), we restrict the coefficients on log  and   to be equal to 
one. The coefficient on (j–70) is the interest rate, r. 
70 , log j WTP 70 , 70 logPWTP
70 , j q
70 , log j q 70 , log j q
70 , 70 PWTP log
Clearly, this approach assumes that the interest rate, r, is constant over time and across 
individuals. In subsequent runs, we relax this assumption by allowing individuals with different 
characteristics to have different discount rates. Specifically, we posit that  ) exp( λ i i r z = , where 
 is a 1×k vector of individual characteristics. Data limitations do not allow us to discriminate 
between a linear discount rate or a hyperbolic one, but we do check whether the discount rate is 
i z
                                                 
7 As a special case, we also consider a simple version of the model that includes only the intercept in the right-hand 
side of equation (7). We use this model without covariates to estimate mean and median WTP, which we discuss in 
Section 5.2. Mean WTP is  ) 1 / 1 ( + Γ ⋅ θ σ , where Γ(•) is the gamma function, and median WTP is 
. 
θ σ
/ 1 )] 5 . 0 ln( [− ⋅
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affected by the time until the discounting takes place by including a dummy variable that takes 
on a value of one for respondents in the age group from 50 to 60 years.  
5. Results 
5.1. Reduced Form 
Results from the reduced-form model with covariates are reported in Table 1. Column 
(A) refers to the data from the Canada study, column (B) to the WTP responses from the U.S. 
study, as does (C), except that it omits African Americans for ease of comparison with the 
Canada sample, which does not include this group.  
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(Standard errors in parentheses.) 
* = significant at the 5% level. ** = significant at the 1% level. 
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Three main findings emerge from the reduced-form regressions of Table 1. First, 
individual characteristics like age, race, education, and income are not important predictors of a 
person’s WTP for the future risk reduction. (The only exception is gender in specification (C).) 
The only significant determinants of WTP are current health status, future health status, and the 
subjective probability of surviving until age 70. As a consequence of the relatively large number 
of regression coefficients that are individually insignificant, likelihood ratio tests of the null 
hypothesis that all slopes are zero fail to reject the null for model (A) and marginally reject it at 
the 5% level for models (B) and (C).8 
Second, the signs of two coefficients are consistent with expectations. Specifically, the 
coefficient on the low-income dummy (bottom 25% of the income distribution), which takes on a 
value of one if income is less than $24,500, is negative, although insignificant, and the sign on 
the log of the probability of living until age 70 is positive (and significant at the 5% level in the 
U.S. study).  
Moreover, respondents who expect that their health will become worse when they are 
older are willing to pay less: their WTP is about one-third lower than that of all other individuals 
in Canada, and about 27% lower for U.S. respondents. This seems reasonable, and in sharp 
contrast with the fact that the coefficient on CHRONIC, a dummy taking on a value if the 
respondent has a chronic respiratory or cardiovascular disease, or cancer, is positive (and 
significant, at least in the U.S. study). The presence of one such chronic illness raises WTP by 
28% to 33%. 
Third, many coefficients are very similar across the two studies. Indeed, a Wald test 
comparing columns (A) and (C) does not reject the null that the coefficients are the same across 
the two studies.  
                                                 
8 The likelihood ratio test of the null hypothesis that all slope coefficients are zero are 10.38 for model (A), 20.02 
for specification (B), and 18.46 for specification (C). 
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These similarities and the result of the Wald test prompted us to pool the data from the 
two studies and estimate the following regression: 
log WTPi =  i i i CANADA ε λ β + ⋅ + x  ,            (9) 
where CANADA is a dummy denoting the study. The scale of the error term ε is allowed to vary 
across the two countries:  1 0 θ θ θ ⋅ + = i i CANADA .  
Results from this specification are reported in Table 2. They confirm that many 
individual characteristics, such as income, education, and age, are not important determinants of 
WTP, although the low-income dummy has the expected negative association with WTP. The 
coefficient on gender is now significant at the 5% level, implying that males hold lower WTP 
values: all else being the same, men’s WTP figures are 10% lower than those of women. 
Table 2. Interval-data reduced form regressions.  
Pooled samples, Weibull distribution of WTP with country-specific shape parameter 
(African Americans excluded from the sample). 
 
Variable Coefficient  Standard  error 
Constant 4.0165  0.560 
Wave 1  -0.1375  0.116 
Age 50 to 59  0.0845  0.111 
Male   -0.2302*  0.114 
Education   -0.0058  0.024 
Bottom 25% of the 
distribution of income 
-0.1160 
0.138 
Health75worse -0.1944^  0.114 
Log chance70  0.1541  0.095 
Chronic illness  0.4173**  0.116 
Canada   -0.8922**  0.137 
Weibull shape: θ0   1.1488**  0.066 
Weibull shape: θ1  0.1968*  0.085 
           ^ = significant at the 10% level. * = significant at the 5% level;  
          ** = significant at the 1% level. 
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Table 2 also confirms that WTP for the future risk reduction is significantly lower if  
(all else being the same) respondents believe that in the future their health will deteriorate 
relative to the present. Specifically, respondents who believe their health at age 75 will be worse 
than it is now hold WTP values that are 18% less than the values of all other respondents. WTP 
is over 50% greater if the respondent currently has a chronic illness. As before, the WTP for the 
future risk reduction increases with the subjective probability of surviving to age 70, but this 
effect is weak.  
5.2. Structural Form 
We estimate the structural form using only respondents in wave 1.9 Assuming that the 
discount rate is constant for all respondents and all ages, we estimate the discount rate to be 8% 
in the Canada study and 4.5% in the U.S. study. The discount rates are estimated very precisely: 
the standard errors around the estimates are 0.7% and 0.55%, respectively. 
Results from the structural-form model with covariates are displayed in Table 3. Since 
the sample size is smaller when attention is restricted to wave 1 respondents, we pool the data 
from the two studies, but exclude U.S. African Americans. Coefficients are often large, and so 
are the standard errors, implying that results should be interpreted with caution. For example, the 
coefficient on the chronic illness dummy is equal to -0.59, and significant at the 10% level, 
implying that persons with these illnesses have discount rates that are 45% lower than those of 
respondents without chronic illnesses. At the same time, the discount rate of low-income 
respondents is 43% higher than that of the other respondents, but this effect is not statistically 
significant. Older respondents have higher discount rates: those in the age group between 50 and 
                                                 
9 We choose to do so because our procedure relies on predicting willingness to pay for a 5 in 1,000 risk reduction at 
age 70 for respondents who are currently between 40 and 60 years old. But willingness to pay for an immediate risk 
reduction is sensitive to the order in which the risk reductions were valued by the respondents in the survey. To be 
conservative, when we estimate models of willingness to pay for the 5 in 1,000 risk change, we restrict attention to 
the responses from those respondents who valued the 5 in 1,000 risk reduction first.  
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59 have a discount rate that is 51% higher than that of younger respondents, the p-value of the 
coefficient being about 0.09.  
Table 3. Structural Form results. r=exp(ziγ) 
  Coefficient Standard  error 
Constant -2.7212**  0.184 
Male   -0.1677  0.227 
Chronic   -0.5897^  0.307 
Bottom 25% distribution of 
income 
0.3570 0.264 
Age 50 to 59 years  0.4131^  0.245 
θ  2.7630** 0.134 
^ = significant at the 10% level. * = significant at the 5% level; ** = significant at the 1% level. 
 
We attempted to estimate a function where the discount rate is a linear function of age 
(and hence of the time until the discounting takes place, which is 70 minus current age), but this 
model behaved poorly, as did the model with hyperbolic discounting. These results are probably 
due to the insufficient variation in the time until the risk reduction occurs. We also attempted to 
control for the country of the study, but the model behaved very poorly when the Canada dummy 
was included. Models that included chronic illness variables in a more disaggregate form 
experienced the same problem. This suggests that the regression results for the structural form 
with covariates are not very robust and should be interpreted with caution.  
We end by comparing mean and median WTP for a future risk reduction, estimated using 
all respondents but with no covariates, with mean and median WTP for a current reduction, 
estimated using the same respondents. These results appear in Table 4. We have previously 
argued that it is likely that WTP for a future risk reduction should be less than WTP for a risk 
reduction that starts immediately. This is borne out by the data. The ratio of mean WTPj,k to mean 
WTPj,j for 40 ≤ j ≤ 60 and k = 70 is 0.44 in the Canadian sample and 0.48 in the U.S. sample. 
This suggests that a latency period of 10 to 30 years, experienced late in life, significantly 
reduces WTP for a reduction in risk of dying. 
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Table 4. Mean and median WTP and VSLs for present v. future risk reductions.  
Weibull interval-data model with no covariates.  
All Figures in 2000 U.S. dollars (PPP conversion from the Canadian dollar). Cleaned samples, 40-to-60 
year-olds.  
 Canada  US 








Mean WTP (standard error) 
 














Median WTP (standard error) 
 














* wave 1 only. N= 438 for Canada, N = 361 for the United States. 
 
Table 4 also translates the WTP estimates into VSL estimates by dividing the WTP by 
5/10,000. Mean VSLs derived from WTP estimates for the future risk reductions for this 40–60 
age group range from $533,000 for Canada to $700,000 for the United States. As is generally the 
case with estimates from contingent valuation surveys, the median VSLs are lower still.  
6. Conclusions 
This paper reports the results of a contingent valuation survey that elicits WTP for current 
and future mortality risk reductions. The survey questionnaire was self-administered by 
respondents in Canada and the United States using a computerized format.  
We examine the responses to the payment questions for the future risk reduction using 
both reduced form and structural form approaches. Using a reduced-form approach, we find that 
WTP for a risk reduction at age 70 relates to the respondents’ expectations about their future 
health status.  
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Using a structural-form approach, we estimate the implicit discount rates to be 8% in 
Canada and 4.5% in the United States. The discount rate appears to depend on age and health 
status, but inference should be made with caution. Our estimates of the discount rate are in line 
with previous estimates of the discount rate in risk reduction tradeoffs, which range from 0.3% 
(Johannesson and Johansson, 1996) to 14% (Viscusi and Moore, 1989).  
Finally, we note that for respondents aged 40 to 60, WTP today for a risk reduction 
occurring at age 70 is less than half of WTP for a current risk reduction of the same size. 
Delaying the time at which the risk reduction occurs significantly reduces WTP, at least for 
respondents in the 40-to-60 age group.  
What are the policy implications of this finding? In its primary analysis of the benefits of 
reducing the maximum contaminant level (MCL) of arsenic in drinking water from 50 parts per 
billion (ppb) to 10 ppb, the U.S. EPA (2000) did not discount the value of a statistical life used to 
value the reduction in lung and bladder cancers that were predicted to occur as a result of the 
rule, even though there is likely to be a lag between the reduction in exposure and the reduction 
in cancers.10 The study estimated that there would be between 21 and 30 fewer cancers per year 
from the reduction in exposure, starting immediately, and used a VSL of $6.1 million (1999 
USD) to value each case. The resulting mortality benefits ($128–$183 million) accounted for 
over 90% of the monetized benefits of the rule. Total annual costs were estimated to be $205.6 
million, implying that the upper bound estimate of benefits was approximately equal to costs. 
Adjusting the $6.1 million VSL to reflect an average gap of 20 years between reduction in 
exposure and reduction in cancer would, according to the results reported above, cause the 
benefit-cost ratio to fall below one-half. Using the VSLs estimated in our study for this valuation 
exercise would have even more dramatic effects in lowering benefits, as our VSL for the United 
States is almost a factor of 10 lower than that used by EPA. 
                                                 
10 In evaluating the health benefits of a reduction in exposure to a carcinogen, the cessation-lag matters, that is, the 
time between cessation of exposure and the reduction in risk.  
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The decision to reduce the MCL for arsenic is, of course, more complicated than the 
previous paragraph would suggest.11 Our purpose in citing this example is to show that allowing 
for a gap between reduction in exposure and reduction in risk can indeed make a difference in a 
policy context.  
                                                 
11 The U.S. EPA Science Advisory Board (U.S. EPA, 2001) criticized the benefits analysis for assuming a zero 
cessation lag, but also noted that no attempt was made to quantify other health benefits, in spite of a rich body of 
epidemiological literature. 
 
16 Resources for the Future  Alberini, Cropper, Krupnick, and Simon 
 Appendix.  
Table A.1. Bid design by country. 
  Initial bid  If yes  If no 
70  150  30 
150  500  70 
500  725  150 
U.S.  
(2000 U.S. dollars) 
725  1,000  500 
100 225 50 
225 750 100 




1,100 1,500 750 
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